HQL vs. HQH

Last updated Jun 4, 2026

HQL (Tekla Life Sciences Investors) and HQH (Tekla Healthcare Investors) are both stocks. Both operate in the Asset Management industry within the Financial Services sector. Over the past 10 years, HQL returned 9.04%/yr vs 6.79%/yr for HQH. A 0.71 correlation means they provide meaningful diversification when combined.

Performance

HQL vs. HQH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tekla Life Sciences Investors (HQL) and Tekla Healthcare Investors (HQH). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, HQL achieves a 7.66% return, which is significantly higher than HQH's 6.70% return. Over the past 10 years, HQL has outperformed HQH with an annualized return of 9.04%, while HQH has yielded a comparatively lower 6.79% annualized return.

HQL

• 1D: -1.46%
• 1M: -1.33%
• YTD: 7.66%
• 6M: 5.52%
• 1Y: 52.68%
• 3Y*: 21.87%
• 5Y*: 8.03%
• 10Y*: 9.04%

HQH

• 1D: -0.89%
• 1M: -1.72%
• YTD: 6.70%
• 6M: 7.27%
• 1Y: 39.35%
• 3Y*: 17.27%
• 5Y*: 6.04%
• 10Y*: 6.79%

*Multi-year figures are annualized to reflect compound growth (CAGR)

HQL vs. HQH - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
HQL Tekla Life Sciences Investors	7.66%	45.48%	11.03%	4.23%	-19.21%	5.52%	23.72%	25.53%	-16.18%	25.41%
HQH Tekla Healthcare Investors	6.70%	34.12%	10.22%	1.22%	-17.27%	7.99%	24.82%	26.80%	-13.08%	15.97%

Correlation

The correlation between HQL and HQH is 0.88, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.88
Correlation (3Y) Calculated over the trailing 3-year period	0.87
Correlation (5Y) Calculated over the trailing 5-year period	0.88
Correlation (10Y) Calculated over the trailing 10-year period	0.88
Correlation (All Time) Calculated using the full available price history since May 5, 1992	0.71

The correlation between HQL and HQH shifts across timeframes, from 0.71 (all time) to 0.88 (10 years), reflecting how their relationship changes across market environments.

Fundamentals

Total Revenue (TTM) HQL : $51.74M HQH : $32.46M
Gross Profit (TTM) HQL : $30.95M HQH : $27.34M
EBITDA (TTM) HQL : $42.48M HQH : $173.45M

Return for Risk

HQL vs. HQH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HQL

HQL Risk / Return Rank: 91
HQL Sharpe Ratio Rank: 92
HQL Sortino Ratio Rank: 91
HQL Omega Ratio Rank: 89
HQL Calmar Ratio Rank: 91
HQL Martin Ratio Rank: 94

HQH

HQH Risk / Return Rank: 84
HQH Sharpe Ratio Rank: 87
HQH Sortino Ratio Rank: 83
HQH Omega Ratio Rank: 81
HQH Calmar Ratio Rank: 82
HQH Martin Ratio Rank: 88

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HQL vs. HQH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Tekla Life Sciences Investors (HQL) and Tekla Healthcare Investors (HQH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	HQL	HQH	Difference
Sharpe ratio: Return per unit of total volatility	2.53	1.94	+0.59
Sortino ratio: Return per unit of downside risk	3.38	2.60	+0.78
Omega ratio: Gain probability vs. loss probability	1.42	1.32	+0.10
Calmar ratio: Return relative to maximum drawdown	5.16	3.04	+2.12
Martin ratio: Return relative to average drawdown	17.13	10.74	+6.40
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

HQL vs. HQH - Sharpe Ratio Comparison

The current HQL Sharpe Ratio is 2.53, which is higher than the HQH Sharpe Ratio of 1.94. The chart below compares the historical Sharpe Ratios of HQL and HQH, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	HQL	HQH	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.53	1.94	+0.59
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.39	0.31	+0.08
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.41	0.32	+0.09
Sharpe Ratio (All Time) Calculated using the full available price history	0.31	0.38	-0.06

Drawdowns

HQL vs. HQH - Drawdown Comparison

The maximum HQL drawdown since its inception was -62.65%, roughly equal to the maximum HQH drawdown of -62.36%. Use the drawdown chart below to compare losses from any high point for HQL and HQH.

Drawdown Indicators

	HQL	HQH	Difference
Max Drawdown Largest peak-to-trough decline	-62.65%	-62.36%	-0.29%
Max Drawdown (1Y) Largest decline over 1 year	-10.25%	-13.01%	+2.76%
Max Drawdown (3Y) Largest decline over 3 years	-25.10%	-21.14%	-3.96%
Max Drawdown (5Y) Largest decline over 5 years	-38.86%	-37.55%	-1.31%
Max Drawdown (10Y) Largest decline over 10 years	-38.86%	-37.55%	-1.31%
Current Drawdown Current decline from peak	-5.21%	-5.00%	-0.21%
Average Drawdown Average peak-to-trough decline	-22.27%	-21.05%	-1.22%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.08%	3.68%	-0.60%

Volatility

HQL vs. HQH - Volatility Comparison

Tekla Life Sciences Investors (HQL) and Tekla Healthcare Investors (HQH) have volatilities of 5.88% and 5.98%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	HQL	HQH	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.88%	5.98%	-0.10%
Volatility (6M) Calculated over the trailing 6-month period	14.11%	14.43%	-0.32%
Volatility (1Y) Calculated over the trailing 1-year period	21.05%	20.40%	+0.65%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	20.61%	19.60%	+1.01%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	22.25%	21.53%	+0.72%

Dividends

HQL vs. HQH - Dividend Comparison

HQL's dividend yield for the trailing twelve months is around 12.05%, less than HQH's 12.22% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
HQH Tekla Healthcare Investors	12.22%	11.56%	14.21%	9.66%	9.50%	8.59%	7.97%	8.24%	10.75%	8.78%	9.80%	11.97%
HQL Tekla Life Sciences Investors	12.05%	10.85%	14.18%	9.44%	9.57%	8.79%	7.90%	8.03%	10.72%	8.25%	12.18%	11.84%

Financials

Frequently Asked Questions

Can I hold both HQL and HQH in my portfolio?

HQL and HQH have a correlation of 0.88, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, HQL or HQH?

HQH has higher volatility (5.98%) compared to HQL (5.88%). In terms of maximum drawdown, HQL dropped -62.65% vs HQH's -62.36%.

Which has better risk-adjusted returns?

HQL currently has the higher Sharpe Ratio (2.53 vs 1.94), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.